Sergei Bobylev\TASS via Getty Images
Andrew Pollard, who is leading clinical trials of Oxford University's COVID-19 vaccine, said Wednesday there is a "small chance" the vaccine will be ready before December 25. he's "optimistic" that the vaccine, developed by the university and drug company AstraZeneca, will have late-stage trial results before the end of the year.It is one of two vaccine being constantly assessed — a so-called "rolling review" — by Europe's medicine regulator.
The vaccine, developed by Oxford University and AstraZeneca, is one of the world's leading vaccine candidates.
Effective treatment vaccine
Biden supporters line up!
95% only bad news(
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: